ProVise Management Group’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,499
Closed -$30.4K 260
2025
Q2
$30.4K Hold
13,499
﹤0.01% 259
2025
Q1
$18.5K Hold
13,499
﹤0.01% 249
2024
Q4
$21.3K Hold
13,499
﹤0.01% 258
2024
Q3
$16.7K Hold
13,499
﹤0.01% 296
2024
Q2
$18.1K Hold
13,499
﹤0.01% 295
2024
Q1
$18.4K Hold
13,499
﹤0.01% 298
2023
Q4
$35.4K Buy
+13,499
New +$32.7K ﹤0.01% 342
2023
Q2
Sell
-13,499
Closed -$38.9K 345
2023
Q1
$38.9K Hold
13,499
﹤0.01% 341
2022
Q4
$31.6K Buy
+13,499
New +$41.2K ﹤0.01% 317
2022
Q1
Sell
-111,189
Closed -$1.43M 374
2021
Q4
$1.43M Hold
111,189
0.13% 148
2021
Q3
$1.54M Buy
111,189
+3,499
+3% +$36.8K 0.15% 142
2021
Q2
$1.11M Hold
107,690
0.11% 161
2021
Q1
$1.04M Hold
107,690
0.11% 158
2020
Q4
$775K Sell
107,690
-46,100
-30% -$306K 0.09% 179
2020
Q3
$724K Sell
153,790
-17,000
-10% -$84.2K 0.1% 172
2020
Q2
$948K Sell
170,790
-4,000
-2% -$16.6K 0.14% 137
2020
Q1
$627K Hold
174,790
0.11% 156
2019
Q4
$1.48M Sell
174,790
-12,560
-7% -$90.7K 0.18% 124
2019
Q3
$1.27M Sell
187,350
-60,000
-24% -$426K 0.17% 130
2019
Q2
$1.66M Sell
247,350
-50,000
-17% -$272K 0.22% 116
2019
Q1
$1.88M Sell
297,350
-12,460
-4% -$96.4K 0.26% 102
2018
Q4
$2.01M Hold
309,810
0.32% 86
2018
Q3
$2.2M Sell
309,810
-21,100
-6% -$117K 0.29% 101
2018
Q2
$1.44K Buy
+330,910
New +$1.22M 0.11% 142

Other funds holding APYX